Valuation: StimCell Energetics Inc.

Market Cap 4.76M 4.26M 3.92M 3.55M 6.64M 452M 6.76M 46.72M 18.76M 238M 17.85M 17.47M 749M P/E 2027 *
-11.2x
P/E 2028 * -
Enterprise Value 4.76M 4.26M 3.92M 3.55M 6.64M 452M 6.76M 46.72M 18.76M 238M 17.85M 17.47M 749M EV / Sales 2027 *
-
EV / Sales 2028 * 7.93x
Free-Float
28.33%
Yield 2027 *
-
Yield 2028 * -
1 week+106.17%
Current month+37.73%
1 month+37.73%
3 months+8.21%
6 months+2.71%
Current year-24.25%
1 week 0.22
Extreme 0.22495
0.3
1 month 0.15
Extreme 0.146964
0.3
Current year 0.15
Extreme 0.146964
0.48
1 year 0.15
Extreme 0.146964
0.48
3 years 0
Extreme 0.0015
3.42
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 74 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
18/12/25 Sell

Director

16,667 0.0807%
17/3/25 Tax

Director

60,841,472 -
25/2/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+106.17%-31.14%-43.10% 4.76M
-0.62%+0.50%+33.92%+60.07% 64.38B
+0.35%+3.20%+14.92%+84.55% 56.16B
+0.53%+1.96%+15.37%+106.81% 54.16B
-3.66%-4.91%+22.72%+49.95% 45.33B
-0.57%-2.17%+19.86%+97.97% 42.25B
-0.15%+1.20%+221.45%+931.28% 40.78B
+3.27%+47.96%+112.67%+96.48% 33.8B
+1.22%-1.39%+13.92%+46.95% 32.25B
-1.29%-1.72%+21.00%-6.85% 23.57B
Average -0.11%+4.25%+44.47%+142.41% 39.27B
Weighted average by Cap. -0.20%+3.64%+49.67%+161.44%

Financials

2027 *2028 *
Net sales - 600K 537K 494K 448K 837K 56.97M 853K 5.89M 2.37M 29.97M 2.25M 2.2M 94.51M
Net income -510K -457K -420K -381K -712K -48.42M -725K -5.01M -2.01M -25.47M -1.91M -1.87M -80.33M -
Net Debt - -
Projected Income Statement - Annual - StimCell Energetics Inc.
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
26/10/26 USD 0.2250 +53.06% 200
22/10/26 USD 0.1470 -41.19% 1,035

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - StimCell Energetics Inc.
  1. Stock Market
  2. Stocks
  3. STME Stock